AGP Picks
View all

Restrain touts AccumulatR potato seed treatment ahead of Scottish field events

Jul. 31, 2026
By AI, Created 11:18 UTC, Jul 31, 2026, AGP -

Restrain used an open day in Malton, England, to showcase its AccumulatR potato seed treatment and point growers toward upcoming trial events in Scotland. The company says the treatment can improve seed efficiency, raise marketable yield and support more uniform crop emergence.

Why it matters: - Restrain is pitching AccumulatR™ as a way for potato growers to get more marketable output from the same seed input. - The treatment is designed to improve seed efficiency, crop value and returns per hectare. - Restrain is also testing whether AccumulatR™ could reduce seed rates in ware production while maintaining target stem densities.

What happened: - Restrain hosted an Open Day with Cockerill’s in Malton on 23 July 2026. - The event brought together growers, seed producers, agronomists and other industry stakeholders. - Restrain used the event to demonstrate AccumulatR™, its potato seed treatment. - Gavin Prentice of SAC Consulting gave a season update and discussed current field trials. - Restrain is inviting growers to see AccumulatR™ again at Potatoes in Practice 2026 on 13 August in Invergowrie, Scotland, at Stand P16.

The details: - AccumulatR™ uses controlled ethylene and temperature management during storage. - Restrain applies the treatment protocol for 120+ days before planting. - The treatment encourages more stems per seed tuber, which leads to more tubers per plant. - AccumulatR-treated seed is said to promote quicker and more uniform crop emergence. - More uniform emergence supports a more even tuber size distribution across the crop. - Restrain says the combined effect lifts marketable yield in Seed Multiplication sized at 28-55 mm and Salad Production sized at 28-45 mm. - Restrain says the treatment has been used commercially for more than 20 years. - The company says customers use it across the UK, from the Black Isle in Scotland to Norfolk. - Restrain says AccumulatR™ has shown consistent results across more than 200 potato varieties. - The company is also offering a trial results booklet with data and commercial results from the 2025/26 season. - At Potatoes in Practice, Restrain plans to show demonstration plots featuring Cara, Hermes, Lady Rosetta, Innovator, Maris Peer, King Russet and Brooke. - Those plots will cover Seed-for-Seed, Seed-for-Salad and selected Seed-for-Ware applications. - Restrain says the treatment may help growers lower input seed requirements while keeping crop performance stable. - The company says early trial work is exploring that ware-production use case. - Restrain describes itself as an international agricultural technology company serving potato, onion and tomato growers across Europe and beyond.

Between the lines: - The pitch centers on a familiar farm challenge: getting more saleable potatoes from tighter input budgets. - Restrain is linking yield improvement with sustainability by framing efficiency as a way to do more with less. - The company is leaning on long commercial use and multi-variety results to support the product’s credibility ahead of more field demonstrations. - Independent trial updates from SAC Consulting help give the presentation more weight than a standalone product launch.

What's next: - Growers can see the product at Potatoes in Practice 2026 in Scotland on 13 August. - Restrain is also pointing interested growers to the SAC Potato Trials Open Day on 2 September 2026 in West Fingask, Aberdeenshire. - The SAC event will feature the latest 2026 field programme work, including an ethylene AccumulatR treatment trial across 19 varieties. - Registration for the SAC event is available by contacting gavin.prentice@sac.co.uk. - More information is available at Restrain's website.

Disclaimer: This article was produced by AGP Wire with the assistance of artificial intelligence based on original source content and has been refined to improve clarity, structure, and readability. This content is provided on an “as is” basis. While care has been taken in its preparation, it may contain inaccuracies or omissions, and readers should consult the original source and independently verify key information where appropriate. This content is for informational purposes only and does not constitute legal, financial, investment, or other professional advice.

Sign up for:

News Center UK

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

News Center UK

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.